ストックスクリーナーアプリを入手
2.97
4.21%
0.12
アフターアワーズ：
2.69
-0.28
-9.43%
Absci Corp (ABSI) 最新ニュース
Earnings call transcript: Absci’s Q2 2025 results disappoint with revenue miss By Investing.com - Investing.com South Africa
Absci Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Absci earnings missed by $0.03, revenue fell short of estimates - Investing.com
Absci Corp SEC 10-Q Report - TradingView
Absci reports Q2 EPS (24c), consensus (21c) - TipRanks
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - GlobeNewswire
Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Absci (ABSI) Expected to Announce Earnings on Tuesday - MarketBeat
Historical volatility pattern of Absci Corporation visualized7-Day Equity Return Range Forecast Model - Newser
Absci Corporation (NASDAQ:ABSI) Receives $8.28 Consensus Price Target from Analysts - MarketBeat
Absci Corp expected to post a loss of 21 cents a shareEarnings Preview - TradingView
Absci Corporation (NASDAQ:ABSI) Receives $8.28 Consensus Price Target from Brokerages - Defense World
Absci Corporation Stock (ABSI) Opinions on $50 Million Public Offering and AI Collaboration - Quiver Quantitative
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Absci, Almirall Expand Collaboration to Include Second Dermatology Target - MarketScreener
Absci (NASDAQ:ABSI) Upgraded to Hold at Wall Street Zen - MarketBeat
Almirall and Absci Corporation Expand Ai Drug Creation Collaboration Adding A Second Dermatology Target - MarketScreener
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - GlobeNewswire
AI Drug Discovery Breakthrough: Absci Lands Second Target After Successfully Designing Undruggable Molecule - Stock Titan
Earnings Preview: Absci Corp to Report Financial Results Post-market on August 12 - 富途牛牛
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Officer Busch Andreas - 富途牛牛
TR | OpenAI4o Maintains Absci Corp(ABSI.US) With Hold Rating, Maintains Target Price $3 - 富途牛牛
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Director VAN HOUTEN FRANS - 富途牛牛
Does Absci Corporation stock perform well during market downturnsAchieve rapid financial growth with smart picks - Jammu Links News
What analysts say about Absci Corporation stockStrong return on assets - Jammu Links News
Andreas Busch Buys 50,000 Shares of Absci Corporation (NASDAQ:ABSI) Stock - MarketBeat
What are analysts’ price targets for Absci Corporation in the next 12 monthsReal Time Tracker For Fast Growth - Jammu Links News
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 - The Manila Times
Absci AI Drug Discovery Pioneer Announces Q2 2025 Earnings Date, Conference Details - Stock Titan
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
Absci Corporation (NASDAQ:ABSI) Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium - MSN
Absci Corporation (NASDAQ:ABSI) Shares Acquired by Royce & Associates LP - MarketBeat
ARK Investment Management LLC Boosts Stock Position in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci Corporation Stock (ABSI) Opinions on $50 Million Public Offering - Quiver Quantitative
Absci Corp's Busch Andreas Buys 50K Shares at $3.04 on 2025-07-28 - AInvest
Absci Corporation Shows Early Signs of Technical StrengthMarket Entry and Exit Point Tips From Traders - metal.it
Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Adds Absci and Iridium - AInvest
Morgan Stanley Has Lowered Expectations for Absci (NASDAQ:ABSI) Stock Price - MarketBeat
Will Absci Corporation Sustain Its Chart BreakoutDaily Volume Spike Trading Signals Detected - metal.it
Absci announces proposed public offering of common stock - MSN
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
Pier 88 Investment Partners LLC Has $762,000 Stock Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Cathie Wood’s ARK ETF adjusts portfolio, buys ABSCI, sells CRISPR - Investing.com
Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs - Nasdaq
Absci Announces Public Offering to Raise Capital - TipRanks
Gold Falls Over 1%; Phillips 66 Posts Upbeat Earnings - Benzinga
Absci shares tumble 16% after pricing discounted stock offering - MSN
Intel, Absci, and AST SpaceMobile Stocks Move Lower in Friday's Pre-Market Session - AInvest
Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Absci stock falls after pricing public offering below market value - Investing.com
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):